Hormonal Health

Gameto Raises $23M to Redefine Reproductive Longevity with Reprogrammed Ovarian Cells

Gameto, a biotechnology startup solving the problem of accelerated ovarian aging to change the trajectory of women’s health and equality, today announced that it has raised a $20M in Series A funding led by Future Ventures, with participation from Bold Capital Partners, Lux Capital, Plum Alley, TA Ventures, Overwater Ventures, Robert Nelsen and Anne Wojcicki. Gameto also raised $3M in Seed funding in March 2020 from a range of notable investors…

Carrot Fertility Partners with imaware to Launch a New At-Home Female Fertility and Wellness Test

Carrot Fertility, the fertility healthcare and family-forming benefits provider for employers and health plans, is launching new capabilities for members to perform at-home fertility hormone and related biomarker monitoring. This custom, one-of-a-kind test kit goes beyond traditional fertility hormone tests to offer a more complete picture of fertility health, enabling earlier action and interventions from the comfort of home. The Female Fertility…

Organon Completes the Acquisition of Forendo Pharma, a Biotech Firm Focused on Women’s Health

Women’s Health Pharma company and Merck spin-off Organon, has completed its recently announced acquisition of Forendo Pharma, a clinical-stage drug development company focused on novel treatments in women’s health. Forendo’s lead candidate, FOR-6219, is an investigational, potentially first-in-class oral 17β-hydroxysteroid dehydrogenase type 1 (HSD17B1) inhibitor entering Phase 2 clinical development for endometriosis. Forendo’s pipeline also includes a preclinical program targeting polycystic ovarian…

Reproductive Health Company Proov Raises a $9.7M Series A to Support Its New “Complete” Hormone Testing Product

Reproductive health company Proov has raised a $9.7M Series A led by Hambrecht Ducera Growth Venture to invest in its newly launched “Complete” product. Other participants in the round include SteelSky Ventures, WCC Partners, LightShip Capital, GingerBread Capital, and Portfolia Proov is known for its PdG test and associated patented protocol, that lets women confirm ovulation quality, which pertains to when ovulation…

Hormonal Health Startup Hormona Wins the Slush 100 Pitching Competition

Women’s Health startup Hormona has won the Slush 100 Pitching Competition which took place last week at Slush Conference in Helsinki, Finland. Hormona is a young healthtech company helping patients detect patterns in their bodies’ rhythm, learn how to tweak them, and get their hormonal health back on track. The Hormona team launched their first product, a data-driven solution for women to…

Organon Announces Plans to Acquire Forendo Pharma, a Biotech Company Targeting Endometriosis and PCOS

Organon and Forendo Pharma today announced that the companies have entered into a definitive agreement, under which Organon will acquire Forendo, a clinical-stage drug development company focused on novel treatments in women’s health. Forendo is pioneering the science of intracrinology, addressing disease through a novel, tissue-specific approach. Its lead clinical compound is an investigational, potentially first-in-class oral 17β-hydroxysteroid dehydrogenase type 1 (HSD17B1)…

UK-based Healthtech Company Forth Raises £1.6M to Invest in Its Female Hormone Mapping Product

UK-based Forth has raised another £1.6M from both UK and overseas investors Forth’s investment round has attracted backing from a consortium of both UK and overseas investors, including, Trajan Scientific and Medical, (Trajan) through its European subsidiary Trajan Scientific Europe Ltd. The new round of funding will be used to further develop and commercialize Forth’s female hormone mapping product. The Development Bank of…

Guud Launches with €350K in Pre-seed Funding to Grow Its Platform for Menstrual Health

50-65% of women in the EU take supplements every day with some spending up to €2500 each year. Yet many of them are unhappy with the products available to them, unsure what is in them and what effect they actually have on their health. A new generation of women’s health companies is now recognizing this large gap in the market and setting…